Filter
727
Filtered Results: 727
Text search:
World
Health
Organization
East
Mediterranean
Region
Featured
Recommendations
89
New Publications
147
Language
Document type
No document type
252
Studies & Reports
238
Guidelines
106
Manuals
41
Strategic & Response Plan
41
Fact sheets
16
Situation Updates
10
Resource Platforms
10
Training Material
8
Infographics
4
Online Courses
1
Countries / Regions
Global
82
Middle East and North Africa
23
Africa
22
Syria
21
Western and Central Europe
17
South–East Asia Region
10
Latin America and the Carribbean
9
Asia
7
West and Central Africa
7
India
7
Nigeria
6
East and Southern Africa
6
South Africa
6
Eastern Europe
5
Yemen
5
Myanmar / Burma
5
Pakistan
4
Kenya
3
Ghana
3
China
3
Iran
3
Afghanistan
3
Russia
3
Sudan
3
Libya
3
Iraq
3
Somalia
3
Nepal
2
Colombia
2
Thailand
2
Ukraine
2
Turkey
2
Sierra Leone
2
Albania
2
Philippines
2
Italy
2
USA
2
Cambodia
2
Jordan
2
Congo, Democratic Republic of
2
Western Pacific Region
2
Lebanon
2
Brazil
2
Ethiopia
2
South Sudan
2
Liberia
2
North Macedonia
1
Serbia
1
Benin
1
Rwanda
1
Cameroon
1
Niger
1
Malawi
1
Morocco
1
Guinea
1
Venezuela
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Paraguay
1
Tunisia
1
Bangladesh
1
Sri Lanka
1
Egypt
1
Greece
1
Georgia
1
Indonesia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
109
Countries
104
Public Health
79
Women & Child Health
58
Key Resources
42
Capacity Building
17
Pharmacy & Technologies
11
Toolboxes
Mental Health
79
COVID-19
65
Planetary Health
57
NTDs
44
Refugee
38
HIV
36
Global Health Education
34
Rapid Response
32
NCDs
32
TB
29
AMR
27
Caregiver
22
Conflict
22
Disability
18
Malaria
17
Pharmacy
16
Polio
12
Zika
9
Cholera
8
Ebola & Marburg
8
Health Financing Toolbox
8
2.0 Rapid Response
6
Natural Hazards
4
Specific Hazards
2
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries provides the first global data showing the devastating...
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 strategy.
This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In addition to the GHO, country profiles with up to 30 indicators are published, with detailed data received...
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create the infrastructure, policies, surveillance and healt...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
Road safety is an issue that does not receive anywhere near the attention it deserves – and it really is one
of our great opportunities to save lives around the world
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
A tool for measuring alcohol policy implementation
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Meeting Report
Bangkok, Thailand 8-11 August 2016
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of chikungunya, yellow fever and Zik...
The brief on key findings from the 2025 edition of the WHO anaemia estimates provides a snapshot of the current status of anaemia among women aged 15–49 years at the country, regional, and global levels, along with progress toward achieving the global anaemia target by 2030, in alignment with the ...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
WHO recommends replacing western blotting and line immunoassays with simpler tests in HIV testing services. These simpler tests include rapid diagnostic tests (RDTs) that can be used at the point-of-care, and enzyme immunoassays (EIAs).
These tests get results to the client faster, produce accura...
